DekaBank Deutsche Girozentrale’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Hold |
24,000
| – | – | ﹤0.01% | 828 |
|
|
2025
Q1 | $1.28M | Hold |
24,000
| – | – | ﹤0.01% | 806 |
|
|
2024
Q4 | $1.07M | Hold |
24,000
| – | – | ﹤0.01% | 865 |
|
|
2024
Q3 | $889K | Sell |
24,000
-5,016
| -17% | -$186K | ﹤0.01% | 912 |
|
|
2024
Q2 | $995K | Buy |
29,016
+5,016
| +21% | +$172K | ﹤0.01% | 880 |
|
|
2024
Q1 | $695K | Hold |
24,000
| – | – | ﹤0.01% | 943 |
|
|
2023
Q4 | $673K | Sell |
24,000
-3,976
| -14% | -$111K | ﹤0.01% | 976 |
|
|
2023
Q3 | $622K | Buy |
27,976
+3,976
| +17% | +$88.4K | ﹤0.01% | 969 |
|
|
2023
Q2 | $964K | Hold |
24,000
| – | – | ﹤0.01% | 889 |
|
|
2023
Q1 | $1.16M | Hold |
24,000
| – | – | ﹤0.01% | 838 |
|
|
2022
Q4 | $881K | Hold |
24,000
| – | – | ﹤0.01% | 909 |
|
|
2022
Q3 | $1.2M | Buy |
24,000
+7,200
| +43% | +$359K | ﹤0.01% | 829 |
|
|
2022
Q2 | $667K | Hold |
16,800
| – | – | ﹤0.01% | 967 |
|
|
2022
Q1 | $627K | Buy |
16,800
+1,500
| +10% | +$56K | ﹤0.01% | 1016 |
|
|
2021
Q4 | $614K | Buy |
15,300
+400
| +3% | +$16.1K | ﹤0.01% | 1050 |
|
|
2021
Q3 | $549K | Hold |
14,900
| – | – | ﹤0.01% | 1028 |
|
|
2021
Q2 | $618K | Hold |
14,900
| – | – | ﹤0.01% | 1024 |
|
|
2021
Q1 | $690K | Sell |
14,900
-7,000
| -32% | -$324K | ﹤0.01% | 974 |
|
|
2020
Q4 | $1.4M | Sell |
21,900
-33,100
| -60% | -$2.12M | 0.01% | 763 |
|
|
2020
Q3 | $2.57M | Buy |
+55,000
| New | +$2.57M | 0.01% | 542 |
|